… T lymphocytes (CTLs) that can recognise mutated cancer cell antigens and thereby enable
tumour cell killing. Yet, a significant cohort of cancer … anti-cancer immunomechanisms. Recent …

… immunotherapy for HCC, we explore the immunobiology of HCC, with a focus on innate and
innate-… Therefore, to target these cells for liver cancer immunotherapy, our understanding of …

… cancer, ILC2s secrete IL-13 and stimulate MDSCs, thereby mediating a detrimental tolerogenic
pathway that could be used as a novel therapeutic target in cancer immunotherapy 77 . …

… Up until now, the effectiveness of cancer immunotherapy has been primarily evaluated based
on tumor regression and the survival prognosis of patients. A representative study involved …

… Cancer immunotherapy has been intensively investigated in both preclinical and clinical …
tumor cells, cancer immunotherapy is based on the ability of the immune system to fight cancer. …

… work between cells of innate immunity including dendritic cells (DCs… cancer cells. Exogenous
reactivation and/or priming of CD8 + T cells can be possible using rational immunotherapy …

… CAR- and NKR-engineered innate killer cells for use in cancer immunotherapy Innate
lymphocytes constitute a heterogeneous group of cells that includes innate lymphoid cells (ILCs, …

… innate populations, can we develop novel immunotherapies that target them and awaken
their inherent ability to become inflammatory and immunostimulatory? I believe this is also true …

… to a revolutionary innovation in cancer immunotherapy. As an important type of … immunotherapy.
However, engineered T cells seem to hit their bottleneck when resistance of cancerous …

… of innate lymphoid cells (ILCs)—a new group of innate immune cells—we are seeing a
brand-new collection of cells that communicate with both the innate … cancer immunotherapies. …